Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results from an 8-Week Randomized, Placebo-Controlled Trial
Crossref DOI link: https://doi.org/10.1007/978-3-030-94960-0_8
Published Online: 2022-04-02
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Joshi, Pallavi
Tampi, Rajesh R.
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-01
Chapter History
First Online: 2 April 2022